Inhibitors of phosphatidylinositol 3-kinase

Details for Australian Patent Application No. 2004234068 (hide)

Owner Novartis AG

Inventors Bruce, Ian; Press, Nicola; Budd, Emma; Ritchie, Cathy; Keller, Thomas Hugo; Le Grand, Darren Mark; Valade, Barbara; Hayler, Judy; Pilgrim, Gaynor Elizabeth; Cuenoud, Bernard

Agent Davies Collison Cave

Pub. Number AU-B-2004234068

PCT Pub. Number WO2004/096797

Priority 0310234.0 02.05.03 GB

Filing date 30 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 11 September 2008

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096797 Priority application(s): WO2004/096797

11 September 2008 Application Accepted

  Published as AU-B-2004234068

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004234069-Quinuclidine derivatives binding to mucarinic M3 receptors

2004234067-Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators